Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-24

Clinical Trial Update: Prostatic Arterial Embolization With SQUID (Ethylene Vinyl Alcohol Copolymer ) [NA]

View source ↗

Summary

A completed clinical trial evaluating prostatic arterial embolization with SQUID (ethylene vinyl alcohol copolymer) for benign prostatic hyperplasia. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SQUID embolic agent (Ethylene vinyl alcohol copolymer)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Prostatic Hyperplasia, Benign | NA | Status: COMPLETED